U.S. Commercial Services Stock News

Without a fresh headline event driving trading, Centerspace (CSR) still gives you some concrete numbers to work with, from recent share performance to reported revenue and net income trends. See our latest analysis for Centerspace. At a share price of US$64.00, Centerspace’s recent performance has been mixed, with a 6.67% 90 day share price return contrasting with a 4.43% year to date share price decline, while the 1 year total shareholder return of 7.93% reflects steadier longer term...

Cal-Maine Foods (CALM) has just combined a softer second-quarter fiscal 2026 earnings update, as egg prices normalized from earlier highs, with the acquisition of Clean Egg LLC’s Texas production assets, which expands its specialty cage-free and free-range footprint. See our latest analysis for Cal-Maine Foods. The recent second quarter update and Clean Egg acquisition come after a mixed run for investors, with a 9.61% 1 month share price return and a 10.45% year to date share price return...

ASA Gold & Precious Metals Limited has released its full-year results for the period ended November 30, 2025, reporting revenue of US$3.98 million and net income of US$664.07 million, while major shareholder Saba Capital Management has continued to add to its position through recent open market purchases. The combination of strong net income figures and ongoing accumulation by Saba Capital Management and other insiders highlights how closely aligned large shareholders and internal...

If you are wondering whether Oracle's share price still reflects solid value or if optimism has gone too far, starting with a clear look at what you are paying for each dollar of the business can help frame that question. Oracle's stock last closed at US$146.67, with returns of a 15.1% decline over 7 days, a 23.8% decline over 30 days, a 25.1% decline year to date, a 13.7% decline over 1 year, 75.4% over 3 years and 148.2% over 5 years, which gives a mixed picture of recent price moves and...

LTC Properties (LTC) has been drawing fresh attention after recent share price gains, with the stock up over the past week, month, and past 3 months as investors reassess this seniors housing focused REIT. See our latest analysis for LTC Properties. The recent share price gain to $36.68 builds on steady momentum, with a 30 day share price return of 4.8% and a 1 year total shareholder return of 13.05% indicating gradually improving sentiment toward LTC Properties. If LTC Properties has your...

AutoZone stock moves after recent performance shift AutoZone (AZO) has caught investor attention after a recent share price move, with the stock up about 14% over the past month and modestly positive over the past 3 months. See our latest analysis for AutoZone. That recent 13.8% 30 day share price return sits alongside a 12.6% year to date share price gain and a 5 year total shareholder return of 206.8%. This suggests that momentum has been supported over longer horizons, even with some...

Why ESCO Technologies' upcoming earnings are drawing fresh attention ESCO Technologies (ESE) is back in focus ahead of its earnings report this Thursday after the bell, with investors watching how expectations compare with its recent record of topping revenue and earnings forecasts. Last quarter, the engineered components and systems supplier reported revenue 15.1% above analyst estimates and 18.1% higher year on year, along with full year EPS guidance that was above consensus, which has...

Home Depot (HD) is back in focus after a busy stretch of company moves, from cutting 800 corporate jobs and calling staff back to the office to rolling out AI tools for pros and expanding higher margin product partnerships. See our latest analysis for Home Depot. Investors have responded to this mix of cost cuts, AI tools for pros and new product partnerships with a 12.53% 1 month share price return and an 11.97% year to date share price return. This comes even as the 1 year total shareholder...

PAR Technology stock performance snapshot PAR Technology (PAR) has drawn investor attention after a sharp pullback, with the share price at $23.57 and negative returns over the past week, month, past 3 months, year, and 5 years. See our latest analysis for PAR Technology. At the current share price of $23.57, PAR Technology’s short term momentum has weakened, with a 7 day share price return of 17.44% and a 30 day share price return of 34.89%, while the 1 year total shareholder return of...

Horace Mann Educators (HMN) just wrapped up FY 2025 with Q4 revenue of US$434.8 million and basic EPS of US$0.89, rounding out a year in which trailing twelve month revenue reached about US$1.7 billion and EPS came in at roughly US$3.97. The company has seen quarterly revenue move from US$409 million in Q4 2024 to US$434.8 million in Q4 2025, with basic EPS over that span ranging between US$0.71 and US$1.42, highlighting how efficiently those premiums and fees are translating into profit. For...

Deckers Outdoor (DECK) has landed squarely on investors’ radar after reporting record third quarter revenue and earnings, lifting full year guidance and pairing those results with active buybacks and fresh HOKA product launches. See our latest analysis for Deckers Outdoor. That mix of record quarterly results, higher guidance, buybacks and fresh HOKA launches has been reflected in the share price, with a 7 day share price return of about 15% and a 90 day share price return of about 41%, even...

Delta Air Lines announced large new aircraft orders from both Airbus and Boeing, including its first direct widebody purchase from Boeing since 2008. The multibillion dollar deals are aimed at modernizing and diversifying Delta's international fleet and expanding premium capacity. The orders add to Delta's ongoing investments in premium services and long haul growth plans. For investors watching NYSE:DAL, this update comes with the stock recently trading at $70.86. The share price sits...

Sagimet Biosciences (SGMT) is back on investors’ radar after partner Ascletis Pharma reported that Denifanstat, also known as ASC40, met all primary and secondary endpoints in a Phase 3 acne trial. See our latest analysis for Sagimet Biosciences. Despite the positive Phase 3 acne data, Sagimet’s 1 day share price return was a 7.32% decline to US$6.08. Its 30 day share price return of 9.75% contrasts with a 20.94% decline over 90 days and a 1 year total shareholder return of 18.52%, suggesting...

If you are wondering whether Rayonier is attractively priced at its current level, or if you are better off waiting, this article walks through what the numbers say about value. Rayonier shares most recently closed at US$22.77, with returns of 1.2% over 7 days, 2.4% over 30 days, 5.4% year to date, and a 1 year return of a 1.9% decline alongside 3 year and 5 year returns of 18.5% and 9.9% declines. Recent coverage has focused on Rayonier's position as a timber and real estate investment...

GRAIL (GRAL) is in focus after submitting the final module of its Premarket Approval application to the US Food and Drug Administration for the Galleri multi cancer early detection blood test. See our latest analysis for GRAIL. The PMA submission arrives after a sharp 6.2% 1 day share price decline to US$98.88. However, the 90 day share price return of 23.51% and 1 year total shareholder return of 187.53% still point to strong recent momentum around the company. If this kind of regulatory...

If you are looking at CrowdStrike Holdings and wondering whether the current share price lines up with the underlying business, this article will walk through what the numbers are actually saying about value. The stock last closed at US$415.36, with returns of 11.5% decline over 7 days, 9.0% decline over 30 days, 8.4% decline year to date, 0.4% decline over 1 year, 262.8% over 3 years and 79.5% over 5 years. These figures give important context before comparing that price to any estimate of...

J&J Snack Foods (JJSF) opened fiscal 2026 with Q1 revenue of US$343.8 million and basic EPS of US$0.05, while trailing twelve month revenue stood at about US$1.6 billion with EPS of US$3.16. Over recent quarters the company has seen revenue move from US$426.8 million in Q4 2024 to US$454.3 million in Q3 2025 and US$410.2 million in Q4 2025, alongside quarterly EPS figures that ranged from US$1.52 to US$2.27 over that stretch before the latest step down. With trailing net margins compressing...

Rigetti Computing previously postponed the launch of its Cepheus-1-108Q quantum computer to at least the end of Q1 2026 due to technical issues, just as competitor IonQ announced a US$1.80 billion acquisition to build in-house manufacturing capabilities. This combination of execution risk and intensifying competition has sharpened investor focus on whether Rigetti’s technology roadmap and resources can support its long-term ambitions in quantum computing. With questions swirling around the...

Palladyne AI Corp. recently announced two defense wins: a mission-critical missile propulsion subsystem contract with a major U.S. defense prime and an Air Force Research Laboratory HANGTIME award leveraging its SwarmOS™ platform for coordinated autonomous systems across space, air, maritime, and land. Together, these contracts deepen Palladyne AI’s role in the U.S. defense industrial base, extend its technology stack into satellites, and add roughly US$1,000,000 of expected 2026 revenue...

Fresh look at Cardinal Health after recent performance Cardinal Health (CAH) is back on many investors’ screens after a mixed stretch in the share price, with a slight 1 day decline, a small 7 day pullback, and modest gains over the past month. See our latest analysis for Cardinal Health. The recent 1 day share price decline of 5.11% comes after a steadier period, with a 90 day share price return of 4.47% alongside a very strong 1 year total shareholder return of 64.34%. This suggests earlier...

United Parcel Service (NYSE:UPS) is rolling out RFID technology across all UPS Store locations as part of a broad operational reset. The company is investing in automation and data driven efficiency tools to improve tracking accuracy and customer experience. UPS is intentionally shifting volume away from Amazon, focusing more on higher margin areas such as healthcare and small and mid sized business deliveries. The turnaround push includes tighter cost control and follows the end of UPS's 16...

Sarepta Therapeutics, Inc. recently received Medsafe approval in New Zealand for its clinical trial application to begin INSIGHTT, a first-in-human Phase 1 study of SRP-1005, an investigational siRNA therapy for Huntington’s Disease that will assess safety and tolerability in about 24 participants. This marks Sarepta’s move beyond Duchenne muscular dystrophy into Huntington’s Disease, an area with no approved disease-modifying treatments targeting the underlying cause. We will now examine...

For readers wondering whether Woodward is still reasonably priced after a strong run, or if the value case has started to thin out, this article focuses squarely on what the current share price might imply. Woodward last closed at US$373.31, with returns of 14.5% over 7 days, 15.9% over 30 days, 20.1% year to date, 97.5% over 1 year, 266.5% over 3 years and 234.1% over 5 years. These figures naturally raise questions about how much of the story might already be reflected in the price. Recent...

Multiple class action lawsuits and legal investigations have been launched against CoreWeave (NasdaqGS:CRWV) over alleged misleading statements about its AI infrastructure capabilities and data center delays. Law firms claim CoreWeave misrepresented risks tied to a key data center provider and overstated capacity, raising concerns about governance and disclosure practices. At the same time, Nvidia has agreed to invest US$2b in CoreWeave and expand their partnership around AI...